• FirefoxInstall the new Firefox »
  •  Dow Up 0.86% Nasdaq Up 0.90%

    Orexigen Therapeutics, Inc. (OREX)

    -NasdaqGS
    5.79 Up 0.15(2.66%) 3:59PM EST
    |After Hours : 5.79 0.00 (0.00%) 4:00PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:5.64
    Open:5.66
    Bid:5.78 x 4000
    Ask:5.79 x 4200
    1y Target Est:10.71
    Beta:2.68
    Earnings Date:May 6 - May 11 (Est.)
    Day's Range:5.60 - 5.79
    52wk Range:3.11 - 7.82
    Volume:1,565,622
    Avg Vol (3m):2,347,770
    Market Cap:714.83M
    P/E (ttm):N/A
    EPS (ttm):-0.32
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for OREX

    Comparison

    Symbol% ChgMkt Cap
    OREXUp 2.66%714.83M
    ABTDown 0.32%71.25B
    GSKUp 1.08%115.30B
    RHHBYDown 0.53%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):12.54
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.53
    Quarterly EPS Est (Mar-15) :-0.17
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):-0.53

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback